3067 Randomized phase II trial of standard daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancer: North Japan Lung Cancer Group Trial NJLCG1102. (September 2015) - Saito, R.; Suzuki, A.; Maemondo, M.; Sugawara, S.; Nakagawa, T.; Taima, K.; Inoue, A.; Matsuno, K.; Usui, K.; Yokoi, T.; Kanbe, M.; Nukiwa, T.